United Kingdom Ulcerative Colitis Market 규모 및 점유율 분석 - 성장 추세 및 예측 (2024 - 2031)

United Kingdom Ulcerative Colitis Market is Segmented By Drug Type (Anti-Inflammatory Drugs, Anti-TNF biologics, Immuno-suppressants, Calcineurin Inhibitors, and Others), By Disease Type (Ulcerative Proctitis, Proctosigmoiditis, Left-sided Colitis, Pancolitis or Universal Colitis, and Fulminant Colitis), By Dosage Form (Parenteral and Oral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies). The report offers the value (in USD million) for the above-mentioned segments.

Competitive overview of United Kingdom Ulcerative Colitis Market

영국 ulcerative colitis 시장에서 운영하는 주요 선수는 AbbVie Inc. (Allergan, Inc.), Merck & Co., Inc., Novartis AG, Bausch Health Companies Inc., Johnson & Johnson, Abbott, COSMO PHARMACEUTICALS, F. Hoffmann-La Roche Ltd, & Pfizer Inc., 등을 포함합니다.

United Kingdom Ulcerative Colitis Market Leaders

  • AbbVie Inc. (모든 회사, Inc.)
  • 머스크 & 주식회사
  • Novartis AG, 이탈리아
  • Bausch 건강 회사 Inc.
  • 존슨 & 존슨
*Disclaimer: Major players are listed in no particular order.

United Kingdom Ulcerative Colitis Market - Competitive Rivalry, 2023

Market Concentration Graph

United Kingdom Ulcerative Colitis Market

Market Consolidated
(Dominated by major players)
Market Fragmented
(Highly competitive with lots of players.)
*Source: Coherent Market Insights